Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021

Keay Nakae Maintained (SONN) at Strong Buy on, Dec 20th, 2021

Keay Nakae of Chardan Capital, Maintained "Sonnet BioTherapeutics Holdings, Inc." (SONN) at Strong Buy on, Dec 20th, 2021.

Keay has made no other calls on SONN in the last 4 months.



There are 2 other peers that have a rating on SONN. Out of the 2 peers that are also analyzing SONN, 0 agree with Keay's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Keay


  • Michael King of "HC Wainwright & Co." Initiated at Strong Buy on, Thursday, December 16th, 2021
  • Kaveri Pohlman of "BTIG" Initiated at Strong Buy on, Wednesday, September 15th, 2021